Sun, Aug 25 5:09am

Compare PTI



Proteostasis Therapeutics Inc [PTI]
$0.68 0.01 (1.45%)

PTI Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 30 Million
PTI Description

Proteostasis Therapeutics Inc is a United States-based company engaged in the biotechnology industry. Its core operations comprise of discovery and development of therapeutics that treat diseases caused by an imbalance in protein biosynthesis process in the body. It has developed the Disease Relevant Translation (DRT) technology platform, a drug screening approach for identifying highly translatable therapeutics. Using this platform, it has identified a new class of small molecules and amplifiers that modulate proteins in the proteostasis network. The products under its development cycle include PTI-428, which is a lead amplifier of CFTR protein. It also focuses on developing PTI-NC-733, PTI-130, Usp14 program and unfolded protein response (UPR) program.


Visit Website

PTI Earnings

EPS -0.39 P/E Ratio 0.00
Previous Earnings Wed, May 8, 2019
Latest Earnings Wed, Aug 7, 2019 (18 days ago) -15.00%

PTI Dividend

Yield --
Ex-Date --
Pay Date --
History --

PTI Charts

$0.62
1 Year
$10.38
Aug 15, 2019
Oct 18, 2018



Symbol Price Day % YTD %
PTI $0.68 -1.45% -80.40%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy